Algo version: 0.98b
CHRS is listed at the NASDAQ Exchange
CHRS [CHRS]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is CHRS stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

On Friday 21st of November 2014, Coherus BioSciences Inc had a stock price of $13.05. If you invested back then, your return now would be a loss of $-11.95 per share or -91.57%

Yes, the average daily trading liquidity for Coherus BioSciences Inc is $2.63 million. You should therefore be able to get in and out of your positions relatively fast.

Coherus BioSciences Inc has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Coherus BioSciences Inc to be high [0.75 out of 1]